• $2.3M
    Market Cap
  • -50.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
05/31/2025
05/31/2024
Income Statement
Total Operating Revenue
303,022
+21.77%
248,841
N/A
Cost of Revenue
40,106
-12.05%
45,599
N/A
Gross Profit
262,916
+29.36%
203,242
N/A
Sales and Marketing Expense
517
-74.96%
2,065
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
Total Operating Expenses
684,281
-0.74%
689,382
N/A
Operating Profit
-421,365
-13.32%
-486,140
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
-127,455
-22.85%
-165,206
N/A
Income before Taxes
-421,365
-13.32%
-486,140
N/A
Income Taxes
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-651,345
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
-651,345
N/A
Basic EPS and Net Income
-0.0001
0.00%
-0.0001
N/A
Diluted EPS and Net Income
-0.0001
0.00%
-0.0001
N/A
Basic Weighted Average Shares
10.7B
+3.86%
10.3B
N/A
Diluted Weighted Average Shares
10.7B
+3.86%
10.3B
N/A
Balance Sheet
Cash and Cash Equivalents
12,952
+1,615.50%
755
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
12,952
+1,615.50%
755
N/A
Total Current Assets
29,085
+35.33%
21,492
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
Total Assets
31,880
-44.23%
57,162
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
135,496
-14.42%
158,321
N/A
Total Current Liabilities
945,963
+7.26%
881,908
N/A
Total Long-Term Debt
249,500
+0.06%
249,361
N/A
Total Long-Term Liabilities
249,500
-1.87%
254,267
N/A
Total Liabilities
1.2M
+5.22%
1.1M
N/A
Retained Earnings
-5.9M
+10.29%
-5.3M
N/A
Total Stockholders Equity
-1.2M
+7.84%
-1.1M
N/A
Total Shares Outstanding
11.6B
+11.46%
10.4B
N/A
Cash Flow
Cash from Operating Activities
-329,627
-31.24%
-479,382
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
341,824
-27.46%
471,224
N/A
Financials Ratio
Gross Margin
86.76%
N/A
N/A
N/A
Operating Margin
-139.05%
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
21.77%
N/A
N/A
N/A
Current Ratio
0.03
N/A
N/A
N/A
Cash Ratio
0.01
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.33
N/A
N/A
N/A
Debt-to-Assets Ratio
12.08
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow